Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When I was working, long weekends didn't exist.
Thanks. I am obviously betting they get financing, this seems like such a great infrastructure play, its almost silly for the banks to not work with them. BWTFDIK? The price is perplexing. Then again too often I have seen huge runs on other companies before they get Q'ed(then they tank), so maybe this pre-news tanking is good in a bizarro way.
I would be happier if we were open tomorrow. Hate short weeks!
Today is the deadline, was Oppenheimer right? Anybody know what is up? I would expect or hope to know something before the weekend. GLTA, TIA
I saw that fight, he got owned by a journeyman. How did he go 23-0? I hate it when they protect guys like that. They didn't do him any favors.
Sweet
You certainly have patience, what with the volatilty up to now. What made you do it today? Was it the volume?
Thanks, not as fun as yours, but it gets the point across.
Either a delayed stimulus bump(why is this still at these levels?), or financing.IMO
Alot more than I just put into it, but encouraging to know I have company at the price I just bought. We can lose money together....J/K
Agreed.
I am showing inconsistencies as well. That is alot of the float, and Level 2 is looking alot more bullish.JMO
Whoa, big buy!
Close at 39, LOL
I thought so, sweet. Looks good.
Where did you get that picture?
I might hold onto to this one for a couple weeks if this does what I think it might. This stock has alot of short term potential, IMO.
In on some 75's, I hope this baby has some steam left. Anything not headed for an immediate Q is good in this environment. GLTA
I am intrigued by the possibility of a substantial decrease in shares.
Good job last two days, GLTA!
Hope that is it, just bought some 12's yesterday. This needs some volume. (Not the dumping variety)
Children's Internet Inc. announced delayed annual 10-K filing
04/03 09:24 AM
On 04/01/2009, Children's Internet Inc. (CITC:$0.12,00$0.00,000.00%) announced that they will be unable to file their next 10-K by the deadline required by the SEC.
Aspyra Inc. announced delayed annual 10-K filing
04/02 10:27 AM
On 03/31/2009, Aspyra Inc. (APY:$0.31,00$0.01,003.33%) announced that they will be unable to file their next 10-K by the deadline required by the SEC.
Airspan Announces Interoperability Testing Center
Expanding End User Selection of WiMAX Devices
04/02 11:16 AM
BOCA RATON, FL -- (MARKET WIRE) -- 04/02/09 -- Airspan Networks Inc. (AIRN:$0.0949,$0.0249,35.57%) , a leading provider of broadband wireless access networks, announced today the creation of its Interoperability Testing (IOT) Center for Mobile WiMAX(TM). The center, located at the Company's over-the-air demonstration facility in the United Kingdom, will conduct IOT testing on an end-to-end Airspan WiMAX infrastructure in a lab environment.
Several companies have already received the IOT stamp of approval from Airspan, including Intel, Sequans, Fujitsu, USI and Gemtek. This affords operators the assurance that devices supported by these prominent silicon developers and manufactured by these Original Design Manufacturers will deliver on the open ecosystem promise of the WiMAX Forum and its member companies.
The IOT lab will test user devices from other manufacturers to certify seamless operability on an Airspan mobile WiMAX infrastructure network. WiMAX standards and profiles have been created by the WiMAX Forum(TM), to ensure an open ecosystem in which user devices from multiple manufacturers can operate seamlessly on the WiMAX infrastructure of another manufacturer. This initiative ensures that users have a larger choice of end user products, including USB dongles, PC cards, WiMAX enabled notebooks, handsets and other mobile Internet devices.
Airspan will be testing customer premises equipment (CPE) from leading manufacturers to facilitate a rapid adoption of devices into customer networks. The testing will be performed over a range of frequency bands from 2.x-3.x GHz.
Additionally the Center is conducting IOT with a range of core network vendors and has already successfully concluded interoperability with Starent, Bridgewater Systems, Hitachi and others.
"Airspan is substantiating the importance of interoperability between user devices, core networking equipment and infrastructure. All key WiMAX vendors will have to ensure user product interoperability in order to succeed in the WiMAX arena," stated Amit Ancikovsky, Airspan President, Sales and Products. "We must all work together to bolster worldwide WiMAX growth and adoption. I invite vendors to join in this initiative and include their products amongst the Airspan IOT tested and approved catalog."
Airspan will continue IOT testing in the lab, as well as continue to develop state-of-the-art user devices such as its MiMAX USB, the world's only quad-band WiMAX USB dongle.
About Airspan Networks Inc. (AIRN:$0.0949,$0.0249,35.57%)
Airspan is a leading WiMAX pure player and the solution-provider of choice for some of the world's largest WiMAX deployments. Developing leading-edge technology for broadband access and IP-telephony, Airspan continues to supply operators around the world with best-of-breed solutions. With direct sales offices throughout Asia, EMEA and the Americas, a worldwide network of resellers and agents, and partnership alliances with major OEMs, Airspan boasts over 100 commercial WiMAX deployments worldwide. www.airspan.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical facts, including statements regarding our strategy, future operations, financial position, future revenues, projected costs, prospects, plans and objectives of management, may be deemed to be forward-looking statements. The words "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "will," "would" and similar expressions or negative variations thereof are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Investors and others are therefore cautioned that a variety of factors, including certain risks, may affect our business and cause actual results to differ materially from those set forth in the forward-looking statements. The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2008. You should read those factors as being applicable to all related forward-looking statements wherever they appear in this press release. We do not assume any obligation to update any forward-looking statements.
For Investor Relations, contact:
Charlotte Laurent-Ottomane
Investor Relations
Tel. +1 561.395.4581
Email: clottomane@airspan.com
For Media Inquiries, contact:
Dori Erann
Director Marketing CommunicationsAirspan Networks Inc. (AIRN:$0.0949,$0.0249,35.57%)
Tel. +1 561.893.8687
Email: derann@airspan.com
Aspyra Announces Optimization of Top-Level Management to Align with Market and Business Strategy
04/02 09:30 AM
CALABASAS, Calif.--(BUSINESS WIRE)-- Aspyra, Inc. (APY:$0.30,00$0.00,000.00%) today announced top-level changes in its management team as part of the Company’s business strategy and reorganization efforts, effective April 1, 2009.
Bruce Miller, Aspyra (APY:$0.30,00$0.00,000.00%) Chief Technology Officer and original founder of Creative Computer Applications, Inc. (CCA), has departed the Company following a 31 year tenure. As part of his agreement, Mr. Miller will be available as a consultant to the Company on an as needed basis. Aspyra (APY:$0.30,00$0.00,000.00%) was formed following a merger acquisition involving CCA and StorCOMM, Inc. in November 2005.
Mr. Ade Lawal, previously Vice President of Strategy and Business Development, will assume the role of Chief Operating Officer (COO). James R. (Skip) Helms, having previously held the position of COO, has moved into the position of Vice President of Strategic Analysis.
Additional changes in top-level management include:
Danny Chin – Director of Operations
Michelle Del Guercio – Vice President of Marketing and Product Management
Scott Treiber – Acting Vice President of Research and Development
Mr. Miller stated, “Given the current state of the economy and the strategic plans of Aspyra (APY:$0.30,00$0.00,000.00%) , I have agreed to relinquish my role as CTO. I have strong belief in the Company, its personnel and its products, and am certain Aspyra (APY:$0.30,00$0.00,000.00%) will experience the success it deserves.â€
Rodney Schutt, Aspyra (APY:$0.30,00$0.00,000.00%) CEO, stated, “It is with great admiration and respect that we say goodbye to Bruce, after his many years of dedication, vision and leadership to Aspyra (APY:$0.30,00$0.00,000.00%) and our employees.†Mr. Schutt also commented on the reorganization, “Following extensive review of our business and innovation strategy, Aspyra’s senior management believes the reorganization is a vital element that will define greater communication and efficiencies throughout the Company.†He continued, “We have built an excellent team of capable people that are experts in their field and are focused on the critical areas of our organization. This further reinforces our strategic imperatives of growth and operational excellence, with commitment to providing quality service and products to our customers, and the future growth of Aspyra.â€
Aspyra’s wide range of departmental solutions, including LIS, RIS, PACS and integrated RIS/PACS improve access to clinical data, images and reports, as well as provide organizations with new channels to streamline workflow, boost efficiency and reduce costs.
About Aspyra (APY:$0.30,00$0.00,000.00%)
Aspyra (APY:$0.30,00$0.00,000.00%) is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's (APY:$0.30,00$0.00,000.00%) highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra (APY:$0.30,00$0.00,000.00%) , its products and services, visit www.aspyra.com.
Safe Harbor Statement
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of the date of this release, including management's own knowledge and assessment of the Company's industry, customers and competition. Factors that could cause Aspyra's (APY:$0.30,00$0.00,000.00%) actual results to differ materially from these forward-looking statements include among others: changes in the Company’s management or other personnel, the competitive environment for Company products and services; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in the Company’s long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.
Source: Aspyra, Inc. (APY:$0.30,00$0.00,000.00%)
Got a small position, mostly cause it is hard to buy a big position without making it move. Small float, and they seem busy.
Outstanding 12,437,150
Float 6,896,799
Or at least a few days,lol...
Sappennin'?
Nice move, IMO. Big moves are always good for somebody. I hope this stays volatile for a while...
Elite Pharmaceuticals Inc. Announces Signing of Strategic Alliance Agreement Epic Pharma, LLC and Epic Investments, LLC
03/25 11:35 AM
On March 18, 2009, Elite Pharmaceuticals Inc. (ELI:$0.2001,$-0.0399,-16.62%) entered into a Strategic Alliance Agreement with Epic Pharma, LLC and Epic Investments, LLC pursuant to which Elite will commence a strategic relationship with Epic, a pharmaceutical company that operates a business synergistic to that of Elite in the research and development, manufacturing, sales and marketing of oral immediate and controlled release drug products. Under the alliance agreement at least eight additional generic drug products will be developed by Epic at Elite's facility with the intent of filing abbreviated new drug applications for obtaining United States Food and Drug Administration (FDA) approval of such generic drugs, (ii) Elite will be entitled to 15% of the profits generated from the sales of such additional generic drug products upon approval by the FDA, and (iii) Epic and Elite will share with each other certain resources, technology and know-how in the development of drug products, which Elite believes will benefit the continued development of its current drug products. In order to provide Elite with the additional capital necessary for the product development and synergies presented by the strategic relationship with Epic, Epic will invest in Elite through the purchase of $3.75 million of newly issued shares of Elite's Series E Convertible Preferred Stock and warrants to purchase additional shares of Elite's Common Stock.
Elite Pharmaceuticals Inc., Special/Extraordinary Shareholders Meeting, Jun 30, 2009
03/25 11:35 AM
Elite Pharmaceuticals Inc. (ELI:$0.2001,$-0.0399,-16.62%) , Special/Extraordinary Shareholders Meeting, Jun 30, 2009 Agenda: To approve amendments to company's certificate of incorporation that (i) increases the number of authorized shares of Common Stock from 210,000,000 shares to 340,000,000 shares and (ii) reduces the par value of the authorized shares of Common Stock from $0.01 to $0.001 per share.
money is good
Looks like a good agreement. Both parties seem to fill needs.
Current report filing (8-K)
Date : 03/23/2009 @ 5:27PM
Source : Edgar (US Regulatory)
Stock : (ELI)
http://ih.advfn.com/p.php?pid=nmona&cb=1237922195&article=36990600&symbol=A%5EELI
Elite Announces Signing of Strategic Alliance Deal with Epic
02:55 PM Eastern Daylight Time, 03/24/2009 (MidnightTrader) -- On March 18, Elite Pharmaceuticals (ELI:$0.22,00$0.09,0069.23%) entered a strategic alliance agreement with Epic Pharma and Epic Investments pursuant to which Elite will commence a strategic relationship with Epic.
At least eight additional generic drug products will be developed by Epic at Elite's facility with the intent of filing abbreviated new drug applications for obtaining FDA approval of such generic drugs.
Elite will be entitled to 15% of the profits generated from the sales of such additional generic drug products upon approval by the FDA and Epic and Elite will share with each other certain resources, technology and know-how in the development of drug products.
Epic will invest in Elite through the purchase of $3.75 million of newly issued shares of Elite's series E convertible preferred stock and warrants to purchase additional shares of Elite shares. Epic will also be entitled to receive additional shares of Elite shares and warrants to purchase shares of Elite's shares upon achievement of certain milestones relating to the eight additional generic drug products to be developed by Epic at Elite's facility.
Price: 0.20, Change: +0.07, Percent Change: +53.85
http://www.midnighttrader.com
There is no symbol, just this...
46072H108 INTERSTATE BAKERIES CORP DEL NEW
Apparently this is the new symbol, or at least what my account shows...no value though, maybe they are worthless?
46072H108 INTERSTATE BAKERIES CORP DEL NEW
It's a Wonder: IBC emerges from bankruptcy [The Kansas City Star, Mo.]
02/03 07:41 PM
Feb. 3--After more than 4 1/2 years, the maker of Wonder Bread, Hostess Twinkies and a host of other iconic brands, has shed bankruptcy protection, preserving 22,000 jobs.
Interstate Bakeries Corp., announced that a $600 million financing plan has been finalized, giving control of the company to a New York investment fund, but leaving its management in place.
"Today marks a new beginning for Interstate Bakeries," Chief Executive Officer Craig Jung said in a statement. "We are now a stronger and more competitive company. With this period behind us, we can now unleash and empower 22,000 IBC employees to better serve our consumers and customers, revitalize our core brands, and launch product innovation that will profitably grow our business."
New York investment firm Ripplewood Holdings has majority control of the Interstate with an investment of $44.2 million in cash and $85.8 million in convertible debt. The other nearly 50 percent will be held by lenders who are helping finance operations once the company emerges from bankruptcy.
Interstate's 19,000 union employees were promised a future equity stake in the company if it grows, in exchange for concessions in pay, benefits and work rules. The Teamsters represent about 8,500 of Interstate's 22,000 workers. The Bakery, Confectionery, Tobacco Workers and Grain Millers Union represents about 8,200 Interstate workers and a host of other unions represent the rest.
Interstate filed for bankruptcy in September 2004.
| Eric Palmer, epalmer@kcstar.com
To see more of The Kansas City Star, or to subscribe to the newspaper, go to http://www.kansascity.com.
Copyright (c) 2009, The Kansas City Star, Mo.
Distributed by McClatchy-Tribune Information Services. For reprints, email tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.
Twinkies maker Interstate Bakeries exits bankruptcy
02/03 05:51 PM
NEW YORK, Feb 3 (Reuters) - Interstate Bakeries Corp (IBCIQ:$0.0060,$-0.0230,-79.31%) , the maker of Wonder Bread and Twinkies snack cakes, said on Tuesday it has emerged from bankruptcy after operating under court protection for more than four years.
Interstate, based in Kansas City, Missouri, filed for bankruptcy protection in September 2004, as a drop in sales and higher costs for ingredients, energy, health care and pensions led to a cash crunch.
Its reorganization plan was approved by the U.S. Bankruptcy Court in Kansas City in December, but its emergence was delayed several weeks as it renegotiated a critical credit agreement with lender GE Capital Corp <GE.N>.
During its bankruptcy protection, the company also revised labor agreements and altered its debt structure.
Under the reorganization plan, private equity firm Ripplewood Holdings will invest $130 million in the company and take it private. Ripplewood will own a 50 percent stake in the company.
Silver Point Finance is also providing $339 million to fund the company's bankruptcy exit, while a credit agreement with GE Capital will provide about $125 million. (Reporting by Emily Chasan; editing by Jeffrey Benkoe)